Requests that the FDA file an application for an abbreviated new animal drug application (ANADA) for a generic oral suspension for Trilostane that differs from the pioneer product, VETORYL CAPSULES, sponsored by Dechra Veterinary Products. under NADA 141-291
🏛 Food and Drug Administration (FDA)FDA-2026-P-4061
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Apr 17, 2026No comment period